From: MAM kinases: physiological roles, related diseases, and therapeutic perspectives—a systematic review
MAM protein | Interacting proteins | Functions | Cellular location | Related diseases | Refs. | |
---|---|---|---|---|---|---|
Mfn2 | Mfn1, Opa1 | MAM tethering, MQC | ER membrane, OMM | Cisplatin-induced acute kidney disease, sepsis-associated intestinal injury, nonalcoholic steatohepatitis, NAFLD, T2DM, diabetic nephropathy, CMT2A | ||
TpMs | Mfn2 | MAM anti-tethering, mitochondrial fragmentation | Mitochondria, cytoplasm, cytoskeleton, desmosomes | Breast cancer, colon cancer | ||
Fis 1 | BAP31, Drp1 | Apoptosis, mitochondrial fragmentation, mitophagy | OMM, peroxisome | AD, citrinin-caused intestinal damage | ||
PACS2 | BAP31, calnexin | MAM integrity, movement of cargo proteins, Ca2+ flux | ER membrane, MAM | DEE66 | ||
VAPB | PTPIP51 | Ca2+ flux | ER membrane, MAM | ALS | [57] | |
IP3R | Grp-75, VDAC, Ero1α | Ca2+ flux, MAM tethering | Smooth ER, MAM, OMM | ALS, AD | ||
FUNDC1 | Drp1, Fis1, calnexin | Mitochondrial fragmentation, mitophagy | OMM | AD, PD | ||
Miga | Vap33 | MAM formation | OMM, ER membrane | ALS | [74] | |
Cav-1 | Mfn2, Drp1 | Mitochondrial elongation | PM, MAM | Breast cancer | [162] | |
NLRP3 | Undergo oligomerization | Inflammasome formation | MAM | Ulcerative colitis, depression, wound healing | ||
PDZD8 | Counter protein not known yet | MAM tethering, nonvesicular lipid transport | ER membrane | T2DM | ||
SYNJ2BP | E-Syt1, RRBP1 | MAM tethering, Ca2+ flux | ER membrane | ALS | [84] |